Capital International Investors Novo Cure LTD Call Options Transaction History
Capital International Investors
- $557 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
271Shares Held
73.5MCall Options Held
971KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$122 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$72.4 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$62.6 Million8.14% of portfolio
-
State Street Corp Boston, MA2.59MShares$29.4 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...